Eurobio Scientific SA (ALERS) — Capital Reinvestment Ratio
Eurobio Scientific SA (ALERS) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (€5.36 Million) in capital expenditures (€1.50 Million). Check Eurobio Scientific SA tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eurobio Scientific SA Capital Reinvestment Ratio (2017–2024)
This chart tracks Eurobio Scientific SA's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see ALERS cash flow conversion.
Annual Capital Reinvestment Ratio for Eurobio Scientific SA (2017–2024)
Year-by-year Capital Reinvestment Ratio for Eurobio Scientific SA from 2017 to 2024. See Eurobio Scientific SA free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €16.70 Million | €3.26 Million | ▲ +28.7% |
| 2023 | 0.15x | €26.77 Million | €4.05 Million | ▲ +130.2% |
| 2022 | 0.07x | €43.07 Million | €2.83 Million | ▲ +134.8% |
| 2021 | 0.03x | €65.92 Million | €1.85 Million | ▼ -33.0% |
| 2020 | 0.04x | €54.93 Million | €2.30 Million | ▼ -86.9% |
| 2019 | 0.32x | €4.99 Million | €1.59 Million | ▼ -79.8% |
| 2017 | 1.58x | €2.48 Million | €3.91 Million | — |